Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 8, Pages 3220-3232
Publisher
American Society for Clinical Investigation
Online
2011-07-11
DOI
10.1172/jci41514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancement of Drug Sensitivity by Knockdown of HIF-1α in Gastric Carcinoma Cells
- (2016) Qun Zhao et al. ONCOLOGY RESEARCH
- Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells
- (2011) Wataru Habano et al. BMC CANCER
- Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett’s oesophagus
- (2011) Anouk van de Winkel et al. HISTOPATHOLOGY
- Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma
- (2010) Jorge Rioja et al. BJU INTERNATIONAL
- Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells
- (2010) N Ouyang et al. BRITISH JOURNAL OF CANCER
- Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy
- (2010) Elizabeth W LaPensee et al. ENDOCRINE-RELATED CANCER
- Evaluation of Computational Docking to Identify Pregnane X Receptor Agonists in the ToxCast Database
- (2010) Sandhya Kortagere et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Pregnane X Receptor PXR Activates theGADD45β Gene, Eliciting the p38 MAPK Signal and Cell Migration
- (2010) Susumu Kodama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
- (2010) Caroline Raynal et al. Molecular Cancer
- Environmental causes of cancer: endocrine disruptors as carcinogens
- (2010) Ana M. Soto et al. Nature Reviews Endocrinology
- Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer
- (2010) Xiaoni Yue et al. PATHOLOGY INTERNATIONAL
- Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)
- (2010) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
- (2009) Andreas Thalheimer et al. BMC CANCER
- Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells
- (2009) Suman Verma et al. BMC CANCER
- PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line
- (2009) Stefan Harmsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells
- (2009) Elizabeth W. LaPensee et al. CANCER LETTERS
- Steroid and xenobiotic receptor in human esophageal squamous cell carcinoma: A potent prognostic factor
- (2009) Daisuke Takeyama et al. CANCER SCIENCE
- Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
- (2009) A. Roidl et al. CLINICAL CANCER RESEARCH
- Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
- (2009) Evanthia Diamanti-Kandarakis et al. ENDOCRINE REVIEWS
- Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and its Role in Human Colon Cancer Chemoresistance
- (2009) Heng Jiang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Elucidating the ‘Jekyll and Hyde’ Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists
- (2009) Arunima Biswas et al. PHARMACEUTICAL RESEARCH
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha
- (2008) Isabel Conde et al. BMC CANCER
- Bisphenol A Induces a Profile of Tumor Aggressiveness in High-Risk Cells from Breast Cancer Patients
- (2008) S. H. Dairkee et al. CANCER RESEARCH
- Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
- (2008) D. Gupta et al. CLINICAL CANCER RESEARCH
- Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
- (2008) D. Meijer et al. ENDOCRINE-RELATED CANCER
- Lessons learned from a decade of clinical trials of high-dose chemotherapy in ovarian cancer
- (2008) J.A. LEDERMANN INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Nuclear receptors of the enteric tract: guarding the frontier
- (2008) Daniel R Schmidt et al. NUTRITION REVIEWS
- The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells
- (2007) Jie Zhou et al. MOLECULAR ENDOCRINOLOGY
- The Phytoestrogen Coumestrol Is a Naturally Occurring Antagonist of the Human Pregnane X Receptor
- (2007) Hongwei Wang et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search